Zymeworks (ZYME) Revenue (2021 - 2026)
Zymeworks recorded quarterly Revenue of $2.4 million in Q1 2026, down 4.25% quarter-over-quarter from $2.5 million in Q4 2025, and down 22.32% year-over-year from $3.1 million in Q1 2025.
Zymeworks' Revenue history runs 6 years deep, the most recent figure standing at $2.4 million for Q1 2026.
- In Q1 2026, Revenue fell 22.32% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $78.6 million (up 35.3% YoY), while the FY2025 annual figure was $106.0 million, up 38.87% from the prior year.
- Revenue came in at $2.4 million for Q1 2026 at Zymeworks, down from $2.5 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $325.0 million in Q4 2022 to a low of $1.9 million in Q1 2022.
- A 5-year average of $32.8 million and a median of $10.0 million in 2024 frame the typical range for Revenue.
- Across the five-year window, Revenue soared 3962.5% in 2022 and tumbled 94.79% in 2023, its largest moves.
- Zymeworks' Revenue stood at $325.0 million in 2022, then sank by 94.79% to $16.9 million in 2023, then jumped by 83.33% to $31.0 million in 2024, then slumped by 91.9% to $2.5 million in 2025, then dropped by 4.25% to $2.4 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $2.4 million, $2.5 million, and $25.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.41 Mn |
| Dec 31, 2025 | 2.52 Mn |
| Sep 30, 2025 | 25.00 Mn |
| Jun 30, 2025 | 48.73 Mn |
| Mar 31, 2025 | 3.10 Mn |
| Dec 31, 2024 | 31.03 Mn |
| Sep 30, 2024 | 16.00 Mn |
| Jun 30, 2024 | 8.00 Mn |
| Mar 31, 2024 | 10.03 Mn |
| Dec 31, 2023 | 16.93 Mn |
| Sep 30, 2023 | 16.51 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 35.58 Mn |
| Dec 31, 2022 | 325.00 Mn |
| Sep 30, 2022 | 2.63 Mn |
| Jun 30, 2022 | 5.44 Mn |
| Mar 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | 8.00 Mn |
| Sep 30, 2021 | 4.40 Mn |